ARTICLE | Management Tracks
Editas shares sink as CSO Albright readies to depart; plus Arcutis, Precirix, Frazier
January 12, 2021 2:25 AM UTC
Editas Medicine Inc. (NASDAQ:EDIT) said CSO Charles Albright will depart Jan. 15 to pursue another opportunity. A search is under way to find a successor. Shares of the genome editing company fell 15% Monday to $76.94.
Immuno-dermatology company Arcutis Biotherapeutics Inc. (NASDAQ:ARQT) hired Matthew Moore as CBO. Most recently, he was VP, corporate business development and alliance management at Allergan Inc., where he led worldwide strategy and BD for the company’s medical aesthetics unit...